Intravenous administration of reprogrammed CD8+ T-lymphocytes reduced the number of tumor emboli in vessels, perivascular, and peribronchial metastases in the lungs of recipient mice in LLC orthotopic model. This evidence concerns the gene CD8A and neoplasm.